<DOC>
	<DOCNO>NCT00144066</DOCNO>
	<brief_summary>A randomized phase III trial platinum-based chemotherapy alone versus platinum-based chemotherapy follow maintenance therapy gefitinib patient stage IIIB/IV NSCLC .</brief_summary>
	<brief_title>A Randomized Phase III Trial Chemotherapy Alone Versus Chemotherapy Followed Gefitinib Stage IIIB/IV Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Histologically cytologically confirm NSCLC Stage IIIB/IV No prior treatment Measurable disease ECOG PS 01 Adequate organ function Age 2074 Written inform consent Pregnancy breast feed Past history drug hypersensitivity SVC syndrome Pleural pericardial effusion require drainage Active infection Interstitial pneumonia active lung fibrosis Symptomatic brain metastasis Active concomitant malignancy Uncontrolled diabetes Uncontrolled heart disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>